The effect of sedatives on occurrence of rebound pain after axillary brachial plexus block

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0004616

Enrollment

Registered

2020-01-08

Start date

2020-02-05

Completion date

Unknown

Last updated

2026-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : Sedation with propofol or dexmedetomidine after axillary nerve block. Propofol group: 2% Propofol maintenance infusion (0.5 to 2.0 µg/mL TCI mode) Dexmedetomidine group: Dexmedetomidine loading

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Forearm surgery patients over 20 years old with ASA (American Society of Anesthesiologists) class I to III Written informed consent

Exclusion criteria

Exclusion criteria: coagulopathy, infection of injection site, allergy to study drugs, neurological abnormalities of operating arm, severe cardiopulmonary disease, history of liver or kidney disease, chronic steroid or opioid use, refusal of regional anesthesia

Design outcomes

Primary

Measure	Time frame
magnitude of pain score increase;incidence of rebound pain	—

Secondary

Measure	Time frame
time to first analgesic request;Opioid consumption via PCA;Rescue analgesics;Incidence of postoperative nausea and vomiting;duration of rebound pain	—

Countries

Korea, Republic of

Contacts

Public ContactHye-won Oh

Ewha Womans University Seoul Hospital

kateoh79@naver.com+82-2-6986-4388

Outcome results